Inotuzumab ozogamicin for the treatment of adult acute lymphoblastic leukemia: past progress, current research and future directions is a research paper published in Journal of Hematology & Oncology (2024). On theSindex it has a DataRank of 0.457. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.457
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →MD Anderson Cancer Center
Grant: Leukemia SPORE CA100632
NIH/NCI Cancer Center
Grant: Support Grant P30 CA016672
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 3P50CA100632-06S1
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: P50 CA100632
FWCI
9.35
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals